The F.D.A. is expected to approve the coronavirus vaccine by Moderna on Friday, ensuring that millions more Americans will have access to inoculation.
Tuesday, December 15, 2020 8:04 AM EST
The review by the F.D.A. confirms Moderna’s earlier assessment that its vaccine had an efficacy rate of 94.1 percent in a trial of 30,000 people. Side effects, including fever, headache and fatigue, were unpleasant but not dangerous, the agency found.
The New York Times
